Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder |
| |
Authors: | Lundberg Johan Tiger Mikael Landén Mikael Halldin Christer Farde Lars |
| |
Institution: | Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. johan.lundberg@ki.se |
| |
Abstract: | The aim of the present clinical positron emission tomography study was to examine if the 5-HTT is a common target, both for tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs). Serotonin transporter (5-HTT) occupancy was estimated during treatment with TCA, SSRI and mirtazapine in 20 patients in remission from depression. The patients were recruited from out-patient units and deemed as responders to antidepressive treatment. The radioligand 11C]MADAM was used to determine the 5-HTT binding potential. The mean 5-HTT occupancy was 67% (range 28-86%). There was no significant difference in 5-HTT occupancy between TCA (n=5) and SSRI (n=14). 5-HTT affinity correlated with the recommended clinical dose. Mirtazapine did not occupy the serotonin transporter. The results support that TCAs and SSRIs have a shared mechanism of action by inhibition of 5-HTT. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|